These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25115387)

  • 1. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
    Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
    Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
    Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
    Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated blastic plasmacytoid dendritic cell neoplasm.
    Loghavi S; Khoury JD
    Blood; 2015 Jul; 126(4):558. PubMed ID: 26421330
    [No Abstract]   [Full Text] [Related]  

  • 4. Blastic plasmacytoid dendritic cell neoplasm with t(2;8)(p12;q24).
    Seiwell AP; Buckley K; Pettenati M; Grier DD
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28097. PubMed ID: 31782605
    [No Abstract]   [Full Text] [Related]  

  • 5. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W; Yu TT; Tang AP; He Young K; Yu L
    Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
    Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
    Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
    Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm.
    Fukuchi K; Koyama D; Takada M; Mori H; Hayashi K; Asano N; Sato Y; Fukatsu M; Takano M; Takahashi H; Shirado-Harada K; Kimura S; Yamamoto T; Ikezoe T
    Int J Hematol; 2023 Oct; 118(4):489-493. PubMed ID: 37029861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms.
    Small C; Mukerjee S; Jangam D; Gollapudi S; Singh K; Jaye DL; Aung PP; Querfeld C; Yao K; Chisholm KM; Pullarkat S; Wang S; Gru A; Hussaini M; George TI; Ohgami RS
    Int J Lab Hematol; 2023 Oct; 45(5):726-734. PubMed ID: 37282364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Khoury JD
    Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.
    Lucioni M; Novara F; Fiandrino G; Riboni R; Fanoni D; Arra M; Venegoni L; Nicola M; Dallera E; Arcaini L; Onida F; Vezzoli P; Travaglino E; Boveri E; Zuffardi O; Paulli M; Berti E
    Blood; 2011 Oct; 118(17):4591-4. PubMed ID: 21900200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
    Ding Y; Yang J; Lindsey K
    Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.
    Dang X; Zhou D; Meng L; Bi L
    J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
    Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F
    Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
    Sapienza MR; Fuligni F; Melle F; Tabanelli V; Indio V; Laginestra MA; Motta G; Mazzara S; Cerroni L; Pileri A; Facchetti F; Paulli M; Cascione L; Laganà A; Berti E; Ferracin M; Agostinelli C; Sabattini E; Croce CM; Pileri SA
    Hematol Oncol; 2020 Dec; 38(5):831-833. PubMed ID: 33405278
    [No Abstract]   [Full Text] [Related]  

  • 19. Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features.
    Künstner A; Schwarting J; Witte HM; Xing P; Bernard V; Stölting S; Lohneis P; Janke F; Salehi M; Chen X; Kusch K; Sültmann H; Chteinberg E; Fischer A; Siebert R; von Bubnoff N; Merz H; Busch H; Feller AC; Gebauer N
    Leukemia; 2024 May; 38(5):1086-1098. PubMed ID: 38600314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
    Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
    Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.